166 related articles for article (PubMed ID: 30616520)
1. Interaction between TP53 and XRCC1 increases susceptibility to cervical cancer development: a case control study.
Liu GC; Zhou YF; Su XC; Zhang J
BMC Cancer; 2019 Jan; 19(1):24. PubMed ID: 30616520
[TBL] [Abstract][Full Text] [Related]
2. The association of polymorphic markers Arg399Gln of XRCC1 gene, Arg72Pro of TP53 gene and T309G of MDM2 gene with breast cancer in Kyrgyz females.
Isakova J; Talaibekova E; Aldasheva N; Vinnikov D; Aldashev A
BMC Cancer; 2017 Nov; 17(1):758. PubMed ID: 29132330
[TBL] [Abstract][Full Text] [Related]
3. Association of DNA Repair Genes XRCC1 and APE-1 with the Risk of Cervical Cancer in North Indian population.
Charles MR; Raza ST; Sharma R; Pratap P; Eba A; Singh M
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2061-2065. PubMed ID: 32711433
[TBL] [Abstract][Full Text] [Related]
4. Impact of Polymorphism in Base Excision Repair and Nucleotide Excision Repair Genes and Risk of Cervical Cancer: A Case-Control Study.
Datkhile KD; Durgawale PP; Patil MN; Gudur RA; Gudur AK; Patil SR
Asian Pac J Cancer Prev; 2022 Apr; 23(4):1291-1300. PubMed ID: 35485688
[TBL] [Abstract][Full Text] [Related]
5. Haplotype analysis of XRCC1 gene polymorphisms and the risk of thyroid carcinoma.
Bashir K; Sarwar R; Fatima S; Saeed S; Mahjabeen I; Akhtar Kayani M
J BUON; 2018; 23(1):234-243. PubMed ID: 29552790
[TBL] [Abstract][Full Text] [Related]
6. Genetic Predisposition to Cervical Cancer and the Association With XRCC1 and TGFB1 Polymorphisms.
Al-Harbi NM; Bin Judia SS; Mishra KN; Shoukri MM; Alsbeih GA
Int J Gynecol Cancer; 2017 Nov; 27(9):1949-1956. PubMed ID: 28906311
[TBL] [Abstract][Full Text] [Related]
7. Elucidation of Increased Cervical Cancer Risk Due to Polymorphisms in XRCC1 (R399Q and R194W), ERCC5 (D1104H), and NQO1 (P187S).
Das AP; Saini S; Tyagi S; Chaudhary N; Agarwal SM
Reprod Sci; 2023 Apr; 30(4):1118-1132. PubMed ID: 36195778
[TBL] [Abstract][Full Text] [Related]
8.
Cavic M; Spasic J; Krivokuca A; Boljevic I; Kuburovic M; Radosavljevic D; Jankovic R
J Clin Pathol; 2019 Jan; 72(1):75-80. PubMed ID: 30467244
[TBL] [Abstract][Full Text] [Related]
9. Association between XRCC1 polymorphisms and the risk of cervical cancer: a meta-analysis based on 4895 subjects.
Zeng X; Zhang Y; Yue T; Zhang T; Wang J; Xue Y; An R
Oncotarget; 2017 Jan; 8(2):2249-2260. PubMed ID: 27903984
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in DNA repair genes and their association with cervical cancer.
Abbas M; Srivastava K; Imran M; Banerjee M
Br J Biomed Sci; 2019 Jul; 76(3):117-121. PubMed ID: 30870085
[No Abstract] [Full Text] [Related]
11. Polymorphisms in XRCC1, ERCC2, and ERCC3 DNA repair genes, CYP1A1 xenobiotic metabolism gene, and tobacco are associated with bladder cancer susceptibility in Tunisian population.
Feki-Tounsi M; Khlifi R; Louati I; Fourati M; Mhiri MN; Hamza-Chaffai A; Rebai A
Environ Sci Pollut Res Int; 2017 Oct; 24(28):22476-22484. PubMed ID: 28803404
[TBL] [Abstract][Full Text] [Related]
12. Male and female breast cancer: the two faces of the same genetic susceptibility coin.
Silva SN; Gomes BC; André S; Félix A; Rodrigues AS; Rueff J
Breast Cancer Res Treat; 2021 Jul; 188(1):295-305. PubMed ID: 33942220
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in HPV E6/E7 protein interacted genes and risk of cervical cancer in Chinese women: a case-control analysis.
Zhou X; Han S; Wang S; Chen X; Dong J; Shi X; Xia Y; Wang X; Hu Z; Shen H
Gynecol Oncol; 2009 Aug; 114(2):327-31. PubMed ID: 19482343
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in cancer susceptibility genes XRCC1, RAD51 and TP53 and the risk of breast cancer in Serbian women.
Krivokuca AM; Cavic MR; Malisic EJ; Rakobradovic JD; Kolarevic-Ivankovic D; Tomasevic ZI; Brankovic-Magic MV
Int J Biol Markers; 2016 Jul; 31(3):e258-63. PubMed ID: 26954070
[TBL] [Abstract][Full Text] [Related]
15. Association between X-Ray Repair Cross-Complementing Group 1 Arg399Gln Polymorphism and Cervical Cancer Risk: A Meta-Analysis in the Chinese Population.
Zhang F; Li B; Wu HY; Shang LX
Gynecol Obstet Invest; 2017; 82(4):382-387. PubMed ID: 27487002
[TBL] [Abstract][Full Text] [Related]
16. TP53 genetic polymorphisms and susceptibility to cervical cancer in Bangladeshi women: a case-control study.
Apu MNH; Rashed AZM; Bashar T; Rahman MM; Mostaid MS
Mol Biol Rep; 2020 Jun; 47(6):4357-4364. PubMed ID: 32424519
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the XRCC1 Arg399Gln gene polymorphism in the development of cervical carcinoma.
Roszak A; Lianeri M; Jagodzinski PP
Int J Biol Markers; 2011; 26(4):216-20. PubMed ID: 21928248
[TBL] [Abstract][Full Text] [Related]
18. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women.
Jiang P; Liu J; Zeng X; Li W; Tang J
Cancer Genet Cytogenet; 2010 Mar; 197(2):174-8. PubMed ID: 20193851
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between mutation of p53 gene 2-4 exons from peripheral blood and HPV16 positive cervical cancer susceptibility and clinical significance].
Yin CM; Yao YF; Yan ZL; Yang HY
Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):320-326. PubMed ID: 28545270
[No Abstract] [Full Text] [Related]
20. DNA base excision repair genes variants rs25487 (X-ray repair cross-complementing 1) and rs1052133 (human 8-oxoguanine glycosylase 1) with susceptibility to ovarian cancer in the population of the Jammu region, India.
Verma S; Sharma V; Nagpal A; Bhat A; Bhat GR; Shah R; Wakhloo A; Suri J; Abrol D; Kaul S; Bhat A; Verma V; Kumar R
J Cancer Res Ther; 2019; 15(6):1270-1275. PubMed ID: 31898659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
